All-Cause Mortality Reductions from Measles Catchup Campaigns in Africa

References

1. ↵
   1. Angrist J. D.,
   2. Krueger A. B.

   1999. “Empirical Strategies in Labor Economics.” In Handbook of Labor Economics, Volume 3A, ed. Ashenfelter O., Card D., 1277–366. Amsterdam: Elsevier Science.

   OpenUrlCrossRef
2. ↵
   1. Barclay A.,
   2. Foster A.,
   3. Sommer A.

   1987. “Vitamin A Supplements and Mortality Related to Measles: A Randomised Clinical Trial.” British Medical Journal (Clinical Research Ed.) 294(6567) (January 31):294–96.

   OpenUrlAbstract/FREE Full Text
3. ↵
   1. Bertrand M.,
   2. Duflo E.,
   3. Mullainathan S.

   2004. “How Much Should We Trust Differencesin-Differences Estimates?” Quarterly Journal of Economics 119(1):249–75.

   OpenUrlCrossRefWeb of Science
4. ↵
   1. Bleakley H

   2010. “Malaria Eradication in the Americas: A Retrospective Analysis of Childhood Exposure.” American Economic Journal: Applied Economics 2(2):1–45.

   OpenUrl
5. ↵
   1. Bolton P.,
   2. Holt E.,
   3. Ross A.,
   4. Hughart N.,
   5. Guyer B.

   1998. “Estimating Vaccination Coverage Using Parental Recall, Vaccination Cards, and Medical Records.” Public Health Reports 113(6):521.

   OpenUrlPubMedWeb of Science
6. ↵
   1. Bryce J.,
   2. Black R.,
   3. Walker N.,
   4. Bhutta Z.,
   5. Lawn J.,
   6. Steketee R.

   2005. “Can the World Afford to Save the Lives of 6 Million Children Each Year?” The Lancet 365(9478): 2193–200.

   OpenUrl
7. ↵
   1. Case A.,
   2. Paxson C.

   2011. “The Impact of the AIDS Pandemic on Health Services in Africa: Evidence from Demographic and Health Surveys.” Demography 48(2):675–97.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Christie A.,
   2. Gay A.

   2011. “The Measles Initiative: Moving Toward Measles Eradication.” Journal of Infectious Diseases 204(Supplement 1):S14–S17.

   OpenUrlCrossRefPubMed
9. ↵
   1. Cutler D.,
   2. Fung W.,
   3. Kremer M.,
   4. Singhal M.,
   5. Vogl T.

   2010. “Early-Life Malaria Exposure and Adult Outcomes: Evidence from Malaria Eradication in India.” American Economic Journal: Applied Economics 2(2):72–94.

   OpenUrlCrossRefWeb of Science
10. ↵
    1. Ferrari M.,
    2. Djibo A.,
    3. Grais R.,
    4. Bharti N.,
    5. Grenfell B.,
    6. Bjornstad O.

    2010. “Rural-Urban Gradient in Seasonal Forcing of Measles Transmission in Niger.” Proceedings of the Royal Society B: Biological Sciences 277(1695):2775–82.

    OpenUrlCrossRefPubMedWeb of Science
11. 1. Ferrari M.,
    2. Djibo A.,
    3. Grais R.,
    4. Grenfell B.,
    5. Bjornstad O.

    2010. “Episodic Outbreaks Bias Estimates of Age-Specific Force of Infection: A Corrected Method Using Measles as an Example.” Epidemiology and Infection 138(01):108–16.

    OpenUrlCrossRefPubMed
12. ↵
    1. Ferrari M.,
    2. Grais R.,
    3. Bharti N.,
    4. Conlan A.,
    5. Bjornstad O.,
    6. Wolfson L.,
    7. Guerin P.,
    8. Djibo A.,
    9. Grenfell B.

    2008. “The Dynamics of Measles in Sub-Saharan Africa.” Nature 451(7179):679–84.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Fortson J

    2009. “HIV/AIDS and Fertility.” American Economic Journal: Applied Economics 1 (3):170–94.

    OpenUrl
14. ↵
    1. Fortson J

    2011. “Mortality Risk and Human Capital Investment: The Impact of HIV/AIDS in Sub-Saharan Africa.” Review of Economics and Statistics 93(1):1–15.

    OpenUrlCrossRef
15. ↵
    1. Helfand R.,
    2. Moss W.,
    3. Harpaz R.,
    4. Scott S.,
    5. Cutts F.

    2005. “Evaluating the Impact of the HIV Pandemic on Measles Control and Elimination.” Bulletin of the World Health Organization 83(5):329–37.

    OpenUrlPubMedWeb of Science
16. ↵
    1. Henao-Restrepo A.,
    2. Strebel P.,
    3. Hoekstra E.,
    4. Birmingham M.,
    5. Bilous J.

    2003. “Experience in Global Measles Control, 1990–2001.” Journal of Infectious Diseases 187(s1):S15–S21.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Imbens G.,
    2. Wooldridge J.

    2009. “Recent Developments in the Econometrics of Program Evaluation.” Journal of Economic Literature 47(1):5–86.

    OpenUrlCrossRefWeb of Science
18. ↵
    1. Kalbeisch J.,
    2. Prentice R.

    1980. The Statistical Analysis of Failure Time Data. New York: Wiley.
19. ↵
    1. Kumar S

    . 2011. “Childhood Immunization, Mortality and Human Capital Accumulation: Micro-Evidence from India.” Seattle: University of Washington.
20. ↵
    1. Lancaster T

    . 1990. The Econometric Analysis of Transition Data. Cambridge: Cambridge University Press.
21. ↵
    1. Levine R

    . 2007. Case Studies in Global Health: Millions Saved. Sudbury: Jones and Bartlett Publishers.
22. ↵
    1. Lim S.,
    2. Stein D.,
    3. Charrow A.,
    4. Murray C.

    2008. “Tracking Progress Towards Universal Childhood Immunisation and the Impact of Global Initiatives: A Systematic Analysis of Three-Dose Diphtheria, Tetanus, and Pertussis Immunisation Coverage.” Lancet 372(9655):2031–46.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    1. Luman E.T.,
    2. Ryman T.K.,
    3. Sablan M.

    2009. “Estimating Vaccination Coverage: Validity of Household-Retained Vaccination Cards and Parental Recall.” Vaccine 27(19):2534–39 doi:10.1016/j.vaccine.2008.10.002.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    1. McKeown T

    . 1979. The Role of Medicine: Dream, Mirage, or Nemesis? Princeton: Princeton University.
25. ↵
    1. McLean A.,
    2. Anderson R.

    1988. “Measles in Developing Countries, Part I: Epidemiological Parameters and Patterns.” Epidemiology and Infection 100(1):111–33.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Measles Initiative

    2011. The Solution. The Measles Initiative. Accessed April 19. http://www.measlesinitiative.org.
27. ↵
    1. Miller M

    2000. “Introducing a Novel Model to Estimate National and Global Measles Disease Burden.” International Journal of Infectious Diseases 4(1):14–20.

    OpenUrlCrossRefPubMed
28. ↵
    1. Moss W.,
    2. Scott S.

    2009. “Module 7: Measles–Update 2009.” In The Immunological Basis for Immunization Series. Geneva: World Health Organization.
29. ↵
    1. Murray C.J.L.,
    2. Shengelia B.,
    3. Gupta N.,
    4. Moussavi S.,
    5. Tandon A.,
    6. Thieren M.

    2003. “Validity of Reported Vaccination Coverage in 45 Countries.” Lancet 362(9389):1022–27.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    1. Otten M.,
    2. Kezaala R.,
    3. Fall A.,
    4. Masresha B.,
    5. Martin R.,
    6. Cairns L.,
    7. Eggers R.,
    8. Biellik R.,
    9. Grabowsky M.,
    10. Strebel P.,
    11. Okwo-Bele J-M.,
    12. Nshimirimana D.

    2005. “Public-Health Impact of Accelerated Measles Control in the WHO African Region 2000–03.” Lancet 366(9488):832–39.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    1. Rajaratnam J.,
    2. Marcus J.,
    3. Flaxman A.,
    4. Wang H.,
    5. Levin-Rector A.,
    6. Dwyer L.,
    7. Costa M.,
    8. Lopez A.,
    9. Murray C.

    2010. “Neonatal, Postneonatal, Childhood, and Under-5 Mortality for 187 Countries, 1970–2010: A Systematic Analysis of Progress Towards Millennium Development Goal 4.” Lancet 375(9730):1988–2008.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    1. Saurabh S.,
    2. Kumar R.

    2012. “Global Reduction in Measles Mortality. Correspondence.” Lancet 380:1303.

    OpenUrlPubMed
33. ↵
    1. Simons E.,
    2. Ferrari M.,
    3. Fricks J.,
    4. Wannemuehler K.,
    5. Anand A.,
    6. Burton A.,
    7. Strebel P.

    2012. “Assessment of the 2010 Global Measles Mortality Reduction Goal: Results from a Model of Surveillance Data.” Lancet 6736(12):60522–24.

    OpenUrl
34. ↵
    1. Stein C.,
    2. Birmingham M.,
    3. Kurian M.,
    4. Duclos P.,
    5. Strebel P.

    2003. “The Global Burden of Measles in the Year 2000: A Model That Uses Country-Specific Indicators.” Journal of Infectious Diseases 187(Supplement1):S8–S14.

    OpenUrlCrossRefPubMedWeb of Science
35. ↵
    1. Strebel P.,
    2. Cochi S.,
    3. Hoekstra E.,
    4. Rota P.,
    5. Featherstone D.,
    6. Bellini W.,
    7. Katz S.

    2011. A World Without Measles.” Journal of Infectious Diseases 204(Supplement 1):S1–S3.

    OpenUrlCrossRefPubMed
36. 1. Suarez L.,
    2. Simpson D.M.,
    3. Smith D.R.

    “Errors and Correlates in Parental Recall of Child Immunizations: Effects on Vaccination Coverage Estimates.” Pediatrics 99(5):E3.
37. ↵
    1. Walker C.L.,
    2. Munos M.K.,
    3. Black R.E.

    2013. “Quantifying the Indirect Effects of Key Child Survival Interventions for Pneumonia, Diarrhoea, and Measles.” Epidemiology and Infection 141(1):115–31.

    OpenUrlCrossRefWeb of Science
38. ↵
    1. Watson J.,
    2. Ramirez E.,
    3. Evens A.,
    4. Bellini W.,
    5. Johnson H.,
    6. Morita J.

    2006. “Measles Immunization Coverage Determined by Serology and Immunization Record from Children in Two Chicago Communities.” Public Health Reports 121(3):262–69.

    OpenUrlPubMed
39. ↵
    1. Wolfson L.,
    2. Grais R.,
    3. Luquero F.,
    4. Birmingham M.,
    5. Strebel P.

    2009. “Estimates of Measles Case Fatality Ratios: A Comprehensive Review of Community-Based Studies.” International Journal of Epidemiology 38(1):192–205.

    OpenUrlCrossRefPubMedWeb of Science
40. ↵
    1. Wolfson L.,
    2. Strebel P.,
    3. Gacic-Dobo M.,
    4. Hoekstra E.,
    5. McFarland J.,
    6. Hersh B.

    2007. “Has the 2005 Measles Mortality Reduction Goal Been Achieved? A Natural History Modelling Study.” The Lancet 369:191–200.

    OpenUrl
41. 1. World Health Organization

    . 2010. “Measles Outbreaks and Progress Towards Meeting Measles Pre-Elimination Goals.” Weekly Epidemiological Record 86(14):129–36.

    OpenUrl